BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3014912)

  • 21. Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature.
    Yu R; Nissen NN; Dhall D; Heaney AP
    Pancreas; 2008 May; 36(4):428-31. PubMed ID: 18437091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
    Skouge JW; Farmer ER
    Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined gastrinoma of the duodenum and glucagonoma of the pancreas].
    Pruglo IuV; Sivtsova NL; Gaĭdar IuA; Gonchar GV
    Arkh Patol; 1987; 49(2):65-70. PubMed ID: 3032131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
    Chang CH; Sheu HM; Cheng GS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagonoma syndrome. Report of two cases and literature review.
    Binnick AN; Spencer SK; Dennison WL; Horton ES
    Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucagonoma syndrome. Unusual histologic image].
    Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
    Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
    Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
    Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.
    Gross TL; O'Brien TD; Davies AP; Long RE
    J Am Vet Med Assoc; 1990 Dec; 197(12):1619-22. PubMed ID: 2276959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent insulinoma syndrome with metastatic glucagonoma.
    Dunn PJ; Sheppard MC; Heath DA; Slaney G
    J Clin Pathol; 1983 Sep; 36(9):1076-80. PubMed ID: 6136529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucagonoma syndrome].
    Coindre MC; Fétissoff F; Lemaire M; Garrigue MA; Lorette G
    Ann Dermatol Venereol; 1985; 112(11):911-4. PubMed ID: 3004309
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
    Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
    J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucagonoma syndrome. Clinico-therapeutic data relative to personal experience and review of the literature].
    Biliotti GC; Vestrini G; Tonelli P; Vallecchi C
    Minerva Chir; 1989 Jan; 44(1-2):163-72. PubMed ID: 2540454
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.